Next Article in Journal
In Vitro-In Silico Tools to Identify Biorelevant Dissolution Specifications for the Selected Poorly-Soluble Model Drugs
Previous Article in Journal
Quality-by-Design Based Characterization of Pharmaceutical Processes by Means of Numerical Simulations
Article Menu

Article Versions

Export Article

Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2015). Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence. Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Open AccessConference Report
Sci. Pharm. 2010, 78(3), 701; https://doi.org/10.3797/scipharm.cespt.8.PPAT12 (registering DOI)

Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets

R&D Institute, Galenika ad, Belgrade, Serbia
*
Author to whom correspondence should be addressed.
Received: 12 July 2010 / Accepted: 12 July 2010 / Published: 12 July 2010
PDF [154 KB, uploaded 11 October 2016]

Abstract

The aim of the study was to present an example of experimental design application to set up the dissolution test conditions for the two immediaterelease products of levothyroxine sodium (L-Na) with proven bioequivalence: the generic product A and the reference product B [1, 2]. [...]
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

KOCIC, I.; HOMSEK, I.; DACEVIC, M. Application of Experimental Design for Screening Study of Dissolution Test Conditions: Levothyroxine Sodium Immediate-Release Tablets. Sci. Pharm. 2010, 78, 701.

Show more citation formats Show less citations formats

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Sci. Pharm. EISSN 2218-0532 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top